Portfolio company
GutSee Health
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops artificial intelligence discovery platforms for microbiome and phage therapies to treat chronic gut disorders and antibiotic-resistant infections for healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Phagos
The company develops AI-powered bacteriophage treatments to combat antibiotic-resistant bacterial diseases, primarily for the animal farming and healthcare sectors.
NostraBiome
This company provides microbiome testing kits and AI-driven health reports for patients and doctors to manage chronic conditions like digestive disorders and cancer.
Gatchealth
This company develops an artificial intelligence platform for drug discovery and risk assessment for biopharmaceutical companies and investors.
GoodGut
This company develops non-invasive faecal diagnostic tests and prebiotic supplements for healthcare professionals and patients to identify and treat digestive diseases.
BiomX
This clinical-stage biotechnology company develops natural and engineered bacteriophage cocktails to treat chronic bacterial infections and inflammatory diseases for healthcare providers and patients.
Florey Biosciences
This company develops engineered probiotics for patients taking antibiotics to protect gut microbiome health and prevent related medical conditions.
GutCRINE
This company develops microbiome-derived pharmabiotics to treat metabolic and age-related disorders including obesity and type-2 diabetes for patients with chronic diseases.
Docbot
This company develops artificial intelligence software for real-time image analysis and automated reporting during gastrointestinal endoscopy procedures for healthcare providers and physicians.
